CTLA4 and melanoma: Although anti-CTLA4 treatment allowed to the overall survival of melanoma to be reached, with even cure of metastatic disease, for about 20% of the patients [46,47,50,51], nevertheless clinical application is limited because of its AIEs [52,53].